The ligand 4(3H)-pyrimidone (Hpm) forms the complexes trans-[PdCl(2)(Hpm)(2)] and [Pd(PP)(Hpm)(2)](CF(3)SO(3))(2) (PP = Ph(2)PCH(2)PPh(2) or Ph(2)P(CH(2))(3)PPh(2)), with the neutral ligand (Hpm), and a bowl-like molecular triangle, [(Pd(bu(2)bipy)(mu-pm))(3)](3+) (bu(2)bipy = 4,4'-di-tert-butyl-2,2'-bipyridine), with the deprotonated ligand (pm). This triangular complex acts as a host for binding of several anionic guests.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: